PMDA drug package insert
リリカカプセル25mg
PMDA Prescription drug · ヴィアトリス製薬合同会社 · package insert Dec 1, 2025
Key facts
| Brand names | リリカカプセル25mg, リリカカプセル75mg, リリカカプセル150mg, リリカOD錠25mg, リリカOD錠75mg, リリカOD錠150mg |
|---|---|
| Nonproprietary names | プレガバリン |
| Companies | 製造販売元／ヴィアトリス製薬合同会社 |
| Product type | Prescription drug |
| Therapeutic category | 疼痛治療剤（神経障害性疼痛・線維筋痛症） |
| Therapeutic category codes | 871190 |
| YJ codes | 1190017M1028, 1190017M2024, 1190017M3020, 1190017F1029, 1190017F2025, 1190017F3021 |
| Approval numbers | 22200AMX00297, 22200AMX00298, 22200AMX00299, 22900AMX00502, 22900AMX00503, 22900AMX00504 |
| Package insert edition | 第8版 |
| Package insert date | Dec 1, 2025 |
| PMDA document key | 671450_1190017F1029_3 |
| PMDA company code | 671450 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: